ArticleJournal of the American Heart Association2020

Polypharmacy, Adverse Outcomes, and Treatment Effectiveness in Patients ≥75 With Atrial Fibrillation.

Nemin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.